Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and fentanyl added to bupivacaine for pain and shivering in lower extremity orthopedic surgery with spinal anesthesia
IRCT20130926014779N4Phase 3Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine, dexmedetomidine and fentanyl in postoperative pain and postanesthetic shivering (PAS), sponsored by Jahrom University of Medical Sciences. Primary endpoints: Postoperative pain intensity and Postoperative shivering incidence or severity. Started Dec 2019; status: completed.
02
Drugs
bupivacainedexmedetomidinefentanyl
03
Conditions
postoperative painpostanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20130926014779N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130926014779N4.